Carbamazepine poisoning: Elimination kinetics and quantitative relationship with carbamazepine 10,11-epoxide

Journal of Toxicology - Clinical Toxicology

Volumn 40, Issue 6, 2002, Pages 759-765

  Winnicka, Renata I ^a   Łopaciński, Bogdan ^a   Szymczak, Wiesław M ^a   Szymańska, Bozena ^a  

^a NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

Author keywords

Acute intoxications; Carbamazepine; Carbamazepine 10,11 epoxide; Elimination kinetics

Indexed keywords

ALCOHOL; CARBAMAZEPINE; CARBAMAZEPINE 10,11 OXIDE; CHARCOAL;

ARTICLE; CLINICAL ARTICLE; COMA; CONTROLLED STUDY; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ELIMINATION; DRUG INTOXICATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; URINALYSIS;

ADULT; ANALGESICS, NON-NARCOTIC; BIOTRANSFORMATION; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM DEPRESSANTS; COMA; ETHANOL; FEMALE; HUMANS; MALE; POISONING;

EID: 0345382877     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-120015836     Document Type: Article

References (17)

1. Gawrońska-Szklarz, B. Carbamazepine. In Monitored Therapy; Adamska-Dyniewska, H., Ed.; Association of Monitored Therapy: Lodz, 1994; 185-192.
2. Kanarkowski, R.; Rybakowski, J. Clinical pharmacokinetics of carbamazepine. Psychiatr. Pol. 1989, 5-6, 389.
3. Mc Namara, J.O. Drugs effective in the therapy of the epilepsis. In The Pharmacological Basis of Therapeutics, 9th Ed.; Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Eds.; Goodman and Gilman's; McGraw-Hill Companies: New York, 1996; 473-475.
4. Feldman, R.; Burda, P.R.; Glińska-Serwin, M.; Kotlarska, M.; Szajewski, J. Correlation between blood carbamazepine concentration and the clinical condition of an intoxicated patient, assessed by using the APPACHE II system, TOXSCORE and comatose state on the Matthew scale. Przegl. Lek. 1997, 54 (6), 410-415.
5. Leikin, J.B.; Paloucek, F.P. Poisoning and Toxicology Handbook; American Pharmaceutical Association, Hudson, 1995-1996; 160-163, 988-991.
6. Sethna, M.; Solomon, G.; Cedarbaum, J.; Kutt, H. Successful treatment of massive carbamazepine overdose. Epilepsia 1989, 30, 71-73.
7. Spina, E.; Martines, C.; Fazio, A. Effect of Phenobarbital on the pharmacokinetics of carbamazepine-10,11-epixode, an active metabolite of carbamazepine. Ther. Drug Monit. 1991, 13, 109.
8. Benet, L.Z.; Kroetz, D.L.; Sheiner, L.B. The dynamics of drug absorption, distribution and elimination. In The Pharmacological Basis of Therapeutics, 9th Ed.; Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W., Eds.; Goodman and Gilman's; McGraw-Hill Companies: New York, 1996; 3-27.
9. Weaver, D.F.; Camfield, P.; Fraser, A. Massive carbamazepine overdose: Clinical and pharmacologic observations in five episodes. Neurology 1998, 38, 755.
10. Hartley, R.; Lucock, M.; Ng, P. Factors influencing plasma level/dose ratios of carbamazepine and its major metabolites in epileptic children. Ther. Drug Monit. 1990, 12, 438.
11. Montgomery, V.L.; Richman, B.J.; Goldsmith, L.J.; Rodgers, G.C., Jr. Severity and carbamazepine level at time of initial poison center contact correlate with outcome in carbamazepine poisoning. Clin. Toxicol. 1995, 33 (4), 311-323.
12. Matthew, H.; Lawson, A.A. Acute barbiturate poisoning, a review of two years experience. Q. J. Med. 1966, 35, 539-552.
13. Mielczarska, J.; Banaszewska, G.; Koszarek-Kranc, A.; Czerski, B. Laboratory Diagnostic of Acute Intoxications; Jakubowski, M., Mielczarska, J., Eds.; Nofer Institute of Occupational Medicine: Lodz, 1996; 72-83.
14. Jobson, J.D. Regression and Experimental Design. Applied Multivariate Data Analysis; Springer-Verlag: New York, 1991.
15. Sen, A.; Srivastava, M. Regression Analysis. Theory, Methods and Applications; Springer-Verlag: New York, 1990.
16. Tiballs, J. Acute toxic reactions to carbamazepine: Clinical effects and serum concentrations. J. Pediatr. 1992, 121, 295-299.
17. Patsalos, P.N.; Krishna, S.; Elyas, A.A.; Lascelles, P.T. Carbamazepine and carbamazepine-10,11-epoxide pharmacokinetics in an overdose patient. Hum. Toxicol. 1987, 6 (3), 241-242.